Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 383

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 383
---
, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and
directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company
completes a business combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released
to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that
a business combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working
Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans will
either be repaid upon consummation of a business combination, without interest, or, at the lender’s discretion, up to $1.5 million
of such Working Capital Loans may be convertible into units of the post business combination entity at a price of $10.00 per unit. The
units would be identical to the Private Placement Units. On December 13, 2022, the Company entered into a promissory note with the
Sponsor. In order to fund ongoing operations, the Sponsor will loan up to $1,500,000 to the Company. The Promissory Note does not
bear interest and matures upon the earlier of (a) the closing of an initial business combination and (b) the Company’s
liquidation. In the event that the Company does not consummate an initial business combination, the Promissory Note will be repaid only
from amounts remaining outside of the Trust Account, if any. On December 8, 2023, the Company and the Lender amended the Promissory Note
to increase the aggregate principal amount of the Promissory Note from $1,500,000 to $1,600,000. All other material terms of the Promissory
Note remain in full force and effect. On May 8, 2023, June 9, 2023, September 12, 2023 and December 18, 2023, the sponsor loaned
the company $250,000, $275,000, $220,000 and $160,000 under the Promissory Note in connection with extensions of the Company’s
liquidation date, respectively. As of December 31, 2023 and 2022, there was $1,555,